Merck KGaA
Science and technology in healthcare, life science, performance materials..
Enterprise value
$60.3b
Share price
$94.79 MRK.DE
Recent deals
Corporate Venture Fund
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 1 % | 22 % | 1 % | 7 % | 1 % | 5 % | 5 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 43 % | 45 % | 17 % | 43 % | 46 % | 47 % | 48 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 27 % | 24 % | 1 % | 27 % | 30 % | 32 % | 33 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 5 % | 5 % | 4 % | 4 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments analysisEdit
ACQUISITION by Merck KGaA Jun 2014
exited
ACQUISITION by Molecular Templates Aug 2017
ACQUISITION by Merck KGaA Dec 2014
ACQUISITION by Merck KGaA Apr 2025
ACQUISITION by Merck KGaA Jul 2024
ACQUISITION by Merck KGaA Aug 2019
ACQUISITION by Merck KGaA Dec 2021